-
Mashup Score: 2Panelists address cost, quality, and disparities in diabetes care - ADA Meeting News - 5 month(s) ago
Osagie Ebekozien, MD, MPH, CPQH, and other experts outlined the ramifications of existing disparities in diabetes care, the importance of person-centered care, and the need for collaboration to improve patient outcomes.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 0
The central nervous system is an essential element in a holistic model of glucose homeostasis, explained Zaman Mirzadeh, MD, PhD. Elevated glucose levels result in insulin release from beta cells, which are glucose sensing, and that has actions on various organs to restore euglycemia.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
It Is All in Your Head: Central Nervous System Control of Systemic Metabolism—Researchers discuss CNS and its role in systemic metabolism during a symposium at the 84th #ADASciSessions. Read the highlights at ADA Meeting News: https://t.co/LiFz04G12Q https://t.co/4LhD3MmSML
-
-
Mashup Score: 3ADA journals convene special symposium to examine topics in heterogeneity of type 1 diabetes - ADA Meeting News - 6 month(s) ago
Better understanding of the implications of metabolic heterogeneity during disease progression may facilitate the development of personalized or pathogenic-derived treatment, explained experts including Carmella Evans-Molina, MD, PhD.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
The Heterogeneity of Type 1 Diabetes: Pathogenesis, Treatment, and Prevention—Various aspects of type 1 diabetes heterogeneity were highlighted during a special joint symposium at the 84th #ADASciSessions. Read an overview at ADA Meeting News: https://t.co/rsG0n1AxAt https://t.co/U5HIUJbdSv
-
-
Mashup Score: 1
Using artificial intelligence (AI) for automated insulin delivery is one way to leverage this new technology in diabetes care, and a recent randomized crossover trial using a neural-net artificial pancreas (NAP) has shown promising results, explained Boris Kovatchev, PhD.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
How Will Artificial Intelligence Change Diabetes Clinical Practice?—Experts discussed the evolving topic of artificial intelligence (AI) in clinical care at the 84th #ADASciSessions. Read the highlights at ADA Meeting News: https://t.co/k1YkIsh5UM https://t.co/ScwaPLCdxL
-
-
Mashup Score: 0Symposium weighs untreated disease risks against diabetes drug risks in pregnancy - ADA Meeting News - 6 month(s) ago
Many people try to avoid medications during pregnancy, hoping to lower the risk of an adverse outcome. However, the risks of high doses of maternal glucose often exceed those of any hypoglycemic drug, explained speakers including Jason G. Umans, MD, PhD.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Myth Busters on “Category X” Drugs in Pregnancy—Experts discussed the potential benefits and complications of using common diabetes drugs during pregnancy at the 84th #ADASciSessions. Read some of the key takeaways at ADA Meeting News: https://t.co/Jez5KN6HQ0 https://t.co/snGhgNt10I
-
-
Mashup Score: 2Experts explain potential of beta-cell replacement therapy for type 1 diabetes - ADA Meeting News - 6 month(s) ago
Despite advances in blood glucose monitoring and insulin delivery, most people living with type 1 diabetes do not meet their glycemic targets. Experts including Anna Lam, MD, MSc, discussed treatment options to help address this gap in care.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Clinical Beta-Cell Replacement Therapy Today—Experts discussed the potential benefits of beta-cell replacement therapy for patients with type 1 diabetes during a joint symposium at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/ehzJttKUPl https://t.co/ONaIR3Tx3G
-
-
Mashup Score: 2CATALYST finds hypercortisolism present in nearly a quarter of patients with difficult-to-control type 2 diabetes - ADA Meeting News - 6 month(s) ago
Study investigators believe their findings strongly highlight the need for improved hypercortisolism screening and treatment approaches in this patient population. Lead author John B. Buse, MD, PhD, said the knowledge that there is a potential secondary cause for difficult-to-control disease may benefit the mental and emotional health of both patients and their providers.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes—Investigators share groundbreaking findings from CATALYST study during a late-breaking session at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/hY9qbzQf3o https://t.co/Kot85e5A1U
-
-
Mashup Score: 9Debate weighs efficacy of AI for personalized nutrition planning - ADA Meeting News - 6 month(s) ago
As with many rapid advancements in artificial intelligence in health care, some question whether the technology is ready for utilization in a real-world environment. Samantha Kleinberg, PhD, and Holly Nicastro, PhD, presented two sides of the debate.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
The Role of Artificial Intelligence in Transforming Nutrition and Diabetes Care: Ready for Prime Time or Not Quite? — Experts debated the merits of AI and personalized nutrition strategies at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/A4UWFWBILg https://t.co/Q8OwvvslZ0
-
-
Mashup Score: 2Symposium outlines patient and economic perspectives of navigating pediatric type 1 diabetes - ADA Meeting News - 6 month(s) ago
Amanda Twigg, MD, discussed being a parent with the disease whose child also has the disease and deciding whether to participate in clinical prevention trials.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Navigating the Early Phases of Pediatric Type 1 Diabetes — Panelists discussed patient views on clinical trials and efforts to reduce costs of type 1 diabetes screening and monitoring at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/idJenVv8xv https://t.co/xTVij0jbIZ
-
-
Mashup Score: 4Experts debate whether immune or beta cells precipitate progression of type 1 diabetes - ADA Meeting News - 6 month(s) ago
Jamie L. Felton, MD, argued that immune cells precipitate disease advancement, while Edward Phelps, PhD, made the case that beta cells are a more influential factor.
Source: www.adameetingnews.orgCategories: General Medicine News, EndocrinologyTweet-
Do Immune or Beta Cells Drive Transition from Stage 1 to Stage 3 Type 1 Diabetes? — Experts debated the underlying mechanisms of progression in type 1 diabetes at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/LTCoasgVIU https://t.co/SAu5qopqR3
-
Improving Diabetes Care and the Cost of Ongoing Inequities—Panelists address disparities in diabetes care at the 84th #ADASciSessions. Read a recap at ADA Meeting News: https://t.co/b0JGGBrAVZ https://t.co/sjkXTV6L8H